ASX - Delayed Quote • AUD EMVision Medical Devices Ltd (EMV.AX) Follow Compare 1.8300 -0.0200 (-1.08%) At close: January 17 at 4:10:20 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations ASX Penny Stock Insights: Acumentis Group Leads Our 3 Stock Analysis The Australian market has shown a modest uptick, with the ASX200 rising by 0.21% to 8,345 points, led by strong performances in the Discretionary and Utilities sectors. For investors looking beyond established giants, penny stocks offer intriguing possibilities as they often encompass smaller or newer companies that might not be on everyone's radar yet hold potential for growth. While the term "penny stocks" may seem outdated, these investments can still provide valuable opportunities when... COSOL Leads Our ASX Penny Stock Spotlight As the ASX 200 shows resilience amidst global concerns, including Trump's tariff discussions and geopolitical tensions, investors are closely watching market movements. Penny stocks, though often seen as a relic of past trading days, continue to present intriguing opportunities for those seeking growth at lower price points. With solid financial foundations and potential for significant returns, these smaller or newer companies offer a chance to uncover hidden value in today’s market landscape. 3 ASX Penny Stocks With Market Caps Under A$200M To Consider Over the last 7 days, the Australian market has remained flat, although it is up 22% over the past year with earnings expected to grow by 12% per annum over the next few years. The term 'penny stocks' might feel like a relic of past market eras, but they still represent potential value and growth opportunities for investors when paired with strong financials. In this article, we'll explore three penny stocks that stand out for their financial strength and potential in today's evolving market... EMVision Medical Devices Full Year 2024 Earnings: AU$0.034 loss per share (vs AU$0.05 loss in FY 2023) EMVision Medical Devices ( ASX:EMV ) Full Year 2024 Results Key Financial Results Revenue: AU$11.6m (up 66% from FY... Australian Medtech EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders SYDNEY, July 23, 2024--EMVision (ASX: EMV), an Australian medical device company focused on the development and commercialisation of innovative portable brain scanning technology, has today unveiled its First Responder Proof of Concept device, designed for deployment via road and air ambulances. Investing in EMVision Medical Devices (ASX:EMV) five years ago would have delivered you a 419% gain It hasn't been the best quarter for EMVision Medical Devices Ltd ( ASX:EMV ) shareholders, since the share price has... EMVision Sets Sight on US With US$10M Keysight Investment SYDNEY, February 28, 2024--EMVision, an Australian medical device company focused on developing innovative portable brain imaging technology, has announced a US$10 million (~A$15.28m) strategic investment from Keysight Technologies, a global leader in test and measurement technology. EMVision Medical Devices (ASX:EMV) shareholders have earned a 35% CAGR over the last five years For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly... Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return EMV.AX S&P/ASX 200 [XJO] YTD -3.43% +1.85% 1-Year -9.85% +12.41% 3-Year -26.51% +12.04%